BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 31170365)

  • 1. DOES T STAGE AFFECT PROGNOSIS IN PATIENTS WITH STAGE IV B DIFFERENTIATED THYROID CANCER?
    Li M; Trivedi N; Dai C; Mao R; Wang Y; Ning Y; Gu SZ; Huo L; Siddiqui AD
    Endocr Pract; 2019 Sep; 25(9):877-886. PubMed ID: 31170365
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparing the Prognostic Value of the Eighth Edition of the American Joint Committee on Cancer/Tumor Node Metastasis Staging System Between Papillary and Follicular Thyroid Cancer.
    van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
    Thyroid; 2018 Aug; 28(8):976-981. PubMed ID: 29848239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TUMOR SIZE IS AN INDEPENDENT PREDICTOR OF MORTALITY RISK IN DIFFERENTIATED THYROID CANCER PATIENTS WITH T4 DISEASE.
    Wang Z; Zhang Q; Ye H; Jia C; Lv Z; Liu J; Yin Z
    Endocr Pract; 2020 May; 26(5):499-507. PubMed ID: 31968190
    [No Abstract]   [Full Text] [Related]  

  • 4. Projecting Survival in Papillary Thyroid Cancer: A Comparison of the Seventh and Eighth Editions of the American Joint Commission on Cancer/Union for International Cancer Control Staging Systems in Two Contemporary National Patient Cohorts.
    Pontius LN; Oyekunle TO; Thomas SM; Stang MT; Scheri RP; Roman SA; Sosa JA
    Thyroid; 2017 Nov; 27(11):1408-1416. PubMed ID: 28891405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the 7th and 8th editions of the AJCC staging system in terms of predicting recurrence and survival in patients with papillary thyroid carcinoma.
    Nam SH; Bae MR; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2018 Dec; 87():158-164. PubMed ID: 30527232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients Aged ≥55 Years With Stage T1-2N1M1 Differentiated Thyroid Cancer Should Be Downstaged in the Eighth Edition AJCC/TNM Cancer Staging System.
    Liu Z; Chen S; Huang Y; Hu D; Wang M; Wei W; Zhang C; Zeng W; Guo L
    Front Oncol; 2019; 9():1093. PubMed ID: 31681617
    [No Abstract]   [Full Text] [Related]  

  • 7. Survival in Differentiated Thyroid Cancer: Comparing the AJCC Cancer Staging Seventh and Eighth Editions.
    Tam S; Boonsripitayanon M; Amit M; Fellman BM; Li Y; Busaidy NL; Cabanillas ME; Dadu R; Sherman S; Waguespack SG; Williams MD; Goepfert RP; Gross ND; Perrier ND; Sturgis EM; Zafereo ME
    Thyroid; 2018 Oct; 28(10):1301-1310. PubMed ID: 30141373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Finding the Optimal Age Cutoff for the UICC/AJCC TNM Staging System in Patients with Papillary or Follicular Thyroid Cancer.
    van Velsen EFS; Visser WE; Stegenga MT; Mäder U; Reiners C; van Kemenade FJ; van Ginhoven TM; Verburg FA; Peeters RP
    Thyroid; 2021 Jul; 31(7):1041-1049. PubMed ID: 33487121
    [No Abstract]   [Full Text] [Related]  

  • 9. Distant metastasis in medullary thyroid carcinoma: Clinical outcomes and implications of T stage.
    Shao Y; Li G; Wei T; Gong R; Li Z; Zhu J; Lei J
    Clin Endocrinol (Oxf); 2022 Nov; 97(5):676-684. PubMed ID: 35261045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A critical analysis of the current TNM classification for differentiated thyroid carcinoma in young patients: Time for a change?
    Wang W; Bai N; Li X
    Front Endocrinol (Lausanne); 2022; 13():939131. PubMed ID: 36339438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Positive Lymph Node Number and Postoperative N-Staging Used to Estimate Survival in Patients with Differentiated Thyroid Cancer: Results from the Surveillance, Epidemiology, and End Results Dataset (1988-2008).
    Wei WJ; Lu ZW; Wen D; Liao T; Li DS; Wang Y; Zhu YX; Wang ZY; Wu Y; Wang YL; Ji QH
    World J Surg; 2018 Jun; 42(6):1762-1771. PubMed ID: 29185020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inclusion of the Number of Metastatic Lymph Nodes in the Staging System for Medullary Thyroid Cancer: Validating a Modified American Joint Committee on Cancer Tumor-Node-Metastasis Staging System.
    Wang Z; Tang C; Wang Y; Yin Z; Rixiati Y
    Thyroid; 2022 May; 32(5):536-543. PubMed ID: 35350868
    [No Abstract]   [Full Text] [Related]  

  • 13. Synergic effects of histology subtype, lymph node metastasis, and distant metastasis on prognosis in differentiated thyroid carcinoma using the SEER database.
    Zhou L; Li Q; Chen S; Huang Y; Wei W; Zhang C; Wang M; Zhou W; Zeng W; Liu Z; Guo L
    Gland Surg; 2020 Aug; 9(4):907-918. PubMed ID: 32953600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival in Papillary Thyroid Microcarcinoma: A Comparative Analysis Between the 7th and 8th Versions of the AJCC/UICC Staging System Based on the SEER Database.
    Yang F; Zhong Q; Huang Z; Lian M; Fang J
    Front Endocrinol (Lausanne); 2019; 10():10. PubMed ID: 30733707
    [No Abstract]   [Full Text] [Related]  

  • 15. Changes in Stage Distribution and Disease-Specific Survival in Differentiated Thyroid Cancer with Transition to American Joint Committee on Cancer 8th Edition: A Systematic Review and Meta-Analysis.
    Lechner MG; Bernardo AC; Lampe A; Praw SS; Tam SH; Angell TE
    Oncologist; 2021 Feb; 26(2):e251-e260. PubMed ID: 32864832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel analysis of prognosis of young patients with stage II differentiated thyroid cancer based on AJCC 8.0 and 6.0 criteria to implement the staging system.
    Huang Y; Zhou L; Zeng W; Chen S; Zhou W; Wei W; Zhang C; Hu D; Wang M; Liu Z; Guo L
    Gland Surg; 2020 Oct; 9(5):1244-1257. PubMed ID: 33224799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is a simplified TNM staging system more clinically relevant than the American Joint Committee on Cancer system for the follicular variant of papillary thyroid cancer?
    Hu D; Huang Y; Zeng W; Chen S; Huang Y; Li M; Long W; Huang J; Wei W; Zhang C; Liu Z; Guo L
    Ann Transl Med; 2020 Apr; 8(7):463. PubMed ID: 32395507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of lymph node metastasis and the eighth edition of AJCC for patients with anaplastic thyroid cancer.
    Zhang H; Zhao YC; Wu Q; Wang L; Sun S
    Clin Endocrinol (Oxf); 2021 Sep; 95(3):498-507. PubMed ID: 33864292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rethinking the 8th AJCC System: Is It Suitable for Patients Aged <55 Years With Stage T4N1M0 Follicular Variant of Papillary Thyroid Carcinoma to Be Placed in Stage I?
    Long W; Hu D; Zhou L; Huang Y; Zeng W; Chen S; Huang Y; Li M; Wang M; Zhou W; Huang J; Wei W; Zhang C; Liu Z; Guo L
    Front Oncol; 2020; 10():543055. PubMed ID: 33425716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Features in Differentiated Thyroid Carcinoma Stratified By Lymph Node Status.
    Shakil J; Cubb TD; Yehya A; Zand A; Xu J; Robbins RJ
    Endocr Pract; 2020 Aug; 26(8):909-914. PubMed ID: 33471682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.